Results 81 to 90 of about 64,150 (161)

Corrigendum: Rethinking immunization programs through the life course approach. [PDF]

Front Public Health
Balsells E, Ghiselli M, Hommes C, Nascimento Lins de Oliveira B, Rosado-Valenzuela AL, Vega E.   +5 more
europepmc   +1 more source

Insights into Predictors of Vaccine Hesitancy and Promoting Factors in Childhood Immunization Programs-A Cross-Sectional Survey in Cameroon. [PDF]

Int J Environ Res Public Health, 2022
Kemeugni Ngandjon J, Ostermann T, Kenmoe V, Laengler A.   +3 more
europepmc   +1 more source

Strengthening Capacity for Tailored Immunization Programs Using Adult Learning Principles: A Case Study from Nigeria. [PDF]

Glob Health Sci Pract
Obi-Jeff C, Oguntimehin F, Adejumo A, Ibrahim A, Ade-Banjo O, Gadzama D, Okoli N, Obi C, Olorupo R, Martins I, Usman A, Joy A, Chadwafwa T, Onimisi A.   +13 more
europepmc   +1 more source

Ethics check-up of public health immunization programs in Canada. [PDF]

Can Commun Dis Rep, 2021
MacDonald NE, Harmon S, Graham JE.
europepmc   +1 more source

Analyzing the usage of theories of change for routine immunization programs -- a review of impact evaluations from LMICs. [PDF]

J Health Popul Nutr
Vadrevu L, Jain M, Parsekar SS.
europepmc   +1 more source

Adults With Autism Should be Considered a Priority in COVID-19 Immunization Programs. [PDF]

J Autism Dev Disord, 2022
Lucena R, de Melo-Carneiro P, Sampaio AS, de Almeida NR, Ponte AMV, de Brito Wanderley D, de Mattos AM, Robatto AP, Argollo N.   +8 more
europepmc   +1 more source

Recommendations for rotavirus immunization programs

Canada Communicable Disease Report, 2014
openaire   +2 more sources

Strategies for introducing and implementing vaccines for adults into national immunization programs in Europe: Good practices and key insights of the adult immunization board meeting. [PDF]

Hum Vaccin Immunother
Boccalini S, Bechini A, Del Riccio M, Weinberger B, Wysocki J, Martinelli D, Wichmann O, Likki T, Hendrickx G, Van Damme P, Wyndham-Thomas C, Bonanni P, Pattyn J.   +12 more
europepmc   +1 more source

Delayed Transition to 20-Valent Pneumococcal Conjugate Vaccine in Pediatric National Immunization Programs: Forgone Public Health and Economic Benefit. [PDF]

Infect Dis Ther
Perdrizet J, Ta A, Huang L, Wannaadisai W, Ilic A, Hayford K, Sabra A.   +6 more
europepmc   +1 more source

Serotype distribution of invasive and non-invasive pneumococcal disease in children ≤5 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines in infant national immunization programs: a systematic literature review. [PDF]

Front Public Health
Izurieta P, AbdelGhany M, Borys D.
europepmc   +1 more source